1/7/2015 | PP | Cerus prices $70 million public offering of its common stock at $5.50
|
3/21/2014 | PP | Cerus arranges $40 million controlled equity offering sales agreement
|
3/14/2013 | PP | Cerus prices $35 million public offering of its common stock at $4.20
|
3/13/2013 | PP | Cerus reports that it plans to price public offering of common shares
|
8/31/2012 | PP | Cerus arranges $30 million controlled equity offering sales agreement
|
1/11/2012 | PP | Cerus to sell up to $20 million of stock in at-the-money offerings
|
12/14/2011 | CVHYPF | Cerus files $150 million shelf covering stock, preferreds, debt
|
8/20/2009 | PP | New Issue: Cerus negotiates $13.2 million private placement of common-share units
|
8/20/2009 | PP | Market Commentary: GTO wraps subscription sale; Poniard arranges equity financing; Cerus to raise $13.2 million
|
10/30/2008 | CVHY | Cerus files $200 million shelf registration
|
12/7/2006 | PP | Market Commentary: Uluru stock jumps 11% on $44.65 million placement; Acusphere to seal $25.46 million direct stock sale
|
12/6/2006 | PP | Market Commentary: Pacific Energy Resources leads slate of oil offerings; Cerus secures $26.07 million from stock offering
|
12/6/2006 | PP | New Issue: Cerus secures $26.08 million from direct placement of stock
|
11/1/2006 | BT | Cerus at $17 price target from JMP
|
9/12/2006 | BT | Cerus starts phase 1 blood transfusion study
|
8/4/2006 | BT | Cerus reiterated at market outperform by JMP
|
5/22/2006 | BT | Cerus kept at market outperform by JMP
|
5/3/2006 | BT | JMP keeps Cerus at market outperform
|
4/18/2006 | BT | Cerus reiterated at market outperform by JMP
|
3/30/2006 | BT | Cerus greenshoe exercised, raising equity issue to $45.3 million
|
3/27/2006 | BT | Cerus clinical data not sufficient, plans for additional phase 3 trial
|
3/21/2006 | BT | Cerus coverage initiated at market outperform by JMP
|
3/16/2006 | BT | New Issue: Cerus raises $39.375 million in follow-on of 4.5 million shares at $8.75 each
|
3/16/2006 | BT | Market Commentary: Novavax, Nastech flu names on a tear; BioMarin higher on trial; Elite bobs, Titan slips on PIPEs
|
2/27/2006 | BT | Cerus plans follow-on offering of 4.5 million shares via Baird, JMP
|
2/27/2006 | BT | Market Commentary: Novavax bags $20 million, up 12%; BioCryst, Generex, Gilead also take flight; Cerus deal emerges
|
2/13/2006 | BT | Cerus obtains rights to Intercept Blood System from Baxter
|
12/30/2005 | BT | Cerus seeks OK to begin phase 1 studies of listeria-based treatment for metastasized liver cancer
|
12/30/2005 | BT | Cerus seeks European approval to market Intercept Blood System for plasma
|
12/1/2005 | BT | Cerus gets $2 million partial payment for commercialization agreement with BioOne
|